An Experimental Study on 131I-CHIBA-1001: A Radioligand for α7 Nicotinic Acetylcholine Receptors

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Yin, Lei ^a   Zhao, Qian ^a,b   Li, Ling ^a   Zhang, Su Lei ^a   Chen, Xue Qi ^a   Ma, Chao ^a   Kang, Lei ^a   Liu, Meng ^a   Zhang, Chun Li ^a   Yan, Ping ^a   Wang, Rong Fu ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAZABICYCLO[3.2.2]NONANE 4 CARBOXYLIC ACID 4 BROMOPHENYL ESTER; BUNGAROTOXIN RECEPTOR; CHIBA 1001 I 131; RADIOLIGAND; SODIUM CHLORIDE; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CEREBELLUM; CONTROLLED STUDY; EXPERIMENTAL STUDY; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; OCCIPITAL CORTEX; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; RADIOCHEMISTRY; RAT; REACTION TIME; ROOM TEMPERATURE; SERUM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNTHESIS; TEMPORAL CORTEX; THALAMUS; THIN LAYER CHROMATOGRAPHY;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; HAPLORHINI; HUMANS; IODINE RADIOISOTOPES; LIGANDS; MALE; MICE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RATS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84880797456     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070188     Document Type: Article

References (37)

1. Romanelli MN, Gratteri P, Guandalini L, Martini E, Bonaccini C, et al. (2007) Central nicotinic receptors: structure, function, ligands, and therapeutic potential. ChemMedChem 2: 746-767.
2. Gotti C, Zoli M, Clementi F, (2006) Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 27: 482-491.
3. Dajas-Bailador F, Wonnacott S, (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25: 317-324.
4. Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, et al. (2008) Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry 165: 1040-1047.
5. Thomsen MS, Hansen HH, Timmerman DB, Mikkelsen JD, (2010) Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr Pharm Des 16: 323-343.
6. Young JW, Finlayson K, Spratt C, Marston HM, Crawford N, et al. (2004) Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29: 891-900.
7. Young JW, Crawford N, Kelly JS, Kerr LE, Marston HM, et al. (2007) Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 17: 145-155.
8. Bodnar AL, Cortes-Burgos LA, Cook KK, Dinh DM, Groppi VE, et al. (2005) Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. J Med Chem 48: 905-908.
9. Hajos M, Hurst RS, Hoffmann WE, Krause M, Wall TM, et al. (2005) The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. J Pharmacol Exp Ther 312: 1213-1222.
10. Wishka DG, Walker DP, Yates KM, Reitz SC, Jia S, et al. (2006) Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure-activity relationship. J Med Chem 49: 4425-4436.
11. Levin ED, Bettegowda C, Blosser J, Gordon J, (1999) AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10: 675-680.
12. Pichat P, Bergis OE, Terranova JP, Urani A, Duarte C, et al. (2007) SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32: 17-34.
13. Hashimoto K, Ishima T, Fujita Y, Matsuo M, Kobashi T, et al. (2008) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711. Biol Psychiatry 63: 92-97.
14. Barak S, Arad M, De Levie A, Black MD, Griebel G, et al. (2009) Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Neuropsychopharmacology 34: 1753-1763.
15. Thomsen MS, Christensen DZ, Hansen HH, Redrobe JP, Mikkelsen JD, (2009) alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 56: 1001-1009.
16. Bitner RS, Bunnelle WH, Anderson DJ, Briggs CA, Buccafusco J, et al. (2007) Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. J Neurosci 27: 10578-10587.
17. Toyohara J, Hashimoto K, (2010) alpha7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease. Open Med Chem J 4: 37-56.
18. Ogawa M, Tatsumi R, Fujio M, Katayama J, Magata Y, (2006) Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agent. Nucl Med Biol 33: 311-316.
19. Hashimoto K, Nishiyama S, Ohba H, Matsuo M, Kobashi T, et al. (2008) [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys. PLoS One 3: e3231.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
21. Hashimoto K, Goromaru T, (1990) High-affinity [3H]6-nitroquipazine binding sites in rat brain. Eur J Pharmacol 180: 273-281.
22. Tanibuchi Y, Wu J, Toyohara J, Fujita Y, Iyo M, et al. (2010) Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human. Brain Res 1348: 200-208.
23. Toyohara J, Wu J, Hashimoto K, (2010) Recent development of radioligands for imaging alpha7 nicotinic acetylcholine receptors in the brain. Curr Top Med Chem 10: 1544-1557.
24. Wu J, Toyohara J, Tanibuchi Y, Fujita Y, Zhang J, et al. (2010) Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for alpha7 nicotinic acetylcholine receptors, to rat brain membranes. Brain Res 1360: 130-137.
25. Segal M, Dudai Y, Amsterdam A, (1978) Distribution of an alpha-bungarotoxin-binding cholinergic nicotinic receptor in rat brain. Brain Res 148: 105-119.
26. Marks MJ, Collins AC, (1982) Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol 22: 554-564.
27. Navarro HA, Zhong D, Abraham P, Xu H, Carroll FI, (2000) Synthesis and pharmacological characterization of [(125)I]iodomethyllycaconitine ([(125)I]iodo-MLA). A new ligand for the alpha(7) nicotinic acetylcholine receptor. J Med Chem 43: 142-145.
28. Navarro HA, Xu H, Zhong D, Abraham P, Carroll FI, (2002) In vitro and in vivo characterization of [125I]iodomethyllycaconitine in the rat. Synapse 44: 117-123.
29. Couturier S, Bertrand D, Matter JM, Hernandez MC, Bertrand S, et al. (1990) A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 5: 847-856.
30. Macallan DR, Lunt GG, Wonnacott S, Swanson KL, Rapoport H, et al. (1988) Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett 226: 357-363.
31. Wang Y, Pereira EF, Maus AD, Ostlie NS, Navaneetham D, et al. (2001) Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol 60: 1201-1209.
32. Li Z, Li HQ, Yan Y, Liu Y, Hao W, et al. (2007) [Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients]. Zhonghua Yi Xue Za Zhi 87: 2105-2108.
33. Gahring LC, Rogers SW, (2005) Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J 7: E885-894.
34. Wang DW, Zhou RB, Yao YM, (2009) Role of cholinergic anti-inflammatory pathway in regulating host response and its interventional strategy for inflammatory diseases. Chin J Traumatol 12: 355-364.
35. Han ZY, Zoli M, Cardona A, Bourgeois JP, Changeux JP, et al. (2003) Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta. J Comp Neurol 461: 49-60.
36. Kulak JM, Schneider JS, (2004) Differences in alpha7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys. Brain Res 999: 193-202.
37. Kulak JM, Carroll FI, Schneider JS, (2006) [125I]Iodomethyllycaconitine binds to alpha7 nicotinic acetylcholine receptors in monkey brain. Eur J Neurosci 23: 2604-2610.